SEC Form 4 · accession 0001214659-15-008517
Anthera Pharmaceuticals Inc · ANTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian Mueller
Director
Period of report
Dec 23, 2015
Accepted (ET)
Dec 24, 2015 · 12:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001316175
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Dec 23, 2015 | M | 10,000 | $2.89 | A | 10,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.89 | Jul 29, 2014 | M | 10,000 | D | — | Jul 29, 2024 | Common Stock | 10,000 | 2,500 | D |
Explanation of responses
- F1The stock option vests and becomes exercisable in 12 equal monthly installments from the vesting commencement date of June 18, 2014. This stock option was fully exercisable on June 18, 2015.